Skip to main content
VCbacked
Log inGet Started

Precede Biosciences

Boston, United States

Precede Biosciences is a biotechnology company that provides a blood-based approach to reveal disease-defining transcriptional biology.

$63.5M raised
Jan 2026
Series B
BiopharmaBiotechnologyHealth CareLife Science

Top Investors

OUP (Osage University Partners)Illumina Ventures5AM VenturesBristol-Myers SquibbLilly Asia Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Precede Biosciences

How much funding has Precede Biosciences raised?
Precede Biosciences has raised $63.5M in total funding. The most recent round was Series B. The last funding was announced in January 2026.
Who are Precede Biosciences's investors?
Precede Biosciences's investors include OUP (Osage University Partners), Illumina Ventures, 5AM Ventures, Bristol-Myers Squibb, Lilly Asia Ventures.
Where is Precede Biosciences headquartered?
Precede Biosciences is headquartered in Boston, United States.
What does Precede Biosciences do?
Precede Biosciences is a biotechnology company that provides a blood-based approach to reveal disease-defining transcriptional biology.
What stage is Precede Biosciences at?
Precede Biosciences is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Precede Biosciences — Funding & Investors." VCBacked, January 12, 2026, https://www.vcbacked.co/company/precede-biosciences. Accessed June 3, 2026.
APA
VCBacked. (2026). Precede Biosciences — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/precede-biosciences
Wikipedia (cite web)
{{cite web |title=Precede Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/precede-biosciences |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
ParcelBio
San Francisco$13.2M
Modicus Prime
Austin
Latus Bio
Philadelphia
Ocugen
Malvern
Ember LifeSciences
Los Angeles$16.5M
ClearNote Health
San Diego